©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 100554
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100554
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100554
Trans-jugular intrahepatic portosystemic stent shunting benefits and limits
Salvatore Stefano Sciarrone, Lucia Fini, Luca De Luca, Department of Surgery, Gastroenterology and Digestive Endoscopy Unit, ASST Santi Paolo e Carlo, University of Milan, Milan 20142, Lombardy, Italy
Co-corresponding authors: Salvatore Stefano Sciarrone and Luca De Luca.
Author contributions: De Luca L, Fini L and Sciarrone SS contribute equally to this article, they wrote the article.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Salvatore Stefano Sciarrone, MD, Department of Surgery, Gastroen
Received: August 19, 2024
Revised: September 19, 2024
Accepted: November 11, 2024
Published online: January 27, 2025
Processing time: 129 Days and 20.6 Hours
Revised: September 19, 2024
Accepted: November 11, 2024
Published online: January 27, 2025
Processing time: 129 Days and 20.6 Hours
Core Tip
Core Tip: The main topic of this article is whether trans-jugular intrahepatic portosystemic stent shunting can be considered a useful strategy for liver recompensation, following the new recommendations of the Baveno guidelines and clinical experience.